Complexity and subtlety of infective endocarditis

Mayo Clinic Proceedings

Volumn 82, Issue 5, 2007, Pages 615-621

  Paterick, Timothy E ^a   Paterick, Timothy J ^a   Nishimura, Rick A ^b   Steckelberg, James M ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL THERAPY; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CLINICAL FEATURE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMAN; MICROBIOLOGY; MORBIDITY; MORTALITY; PHYSICAL EXAMINATION; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; TREATMENT INDICATION; UNITED STATES;

EID: 34248193947     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.5.615     Document Type: Review

References (40)

1. Bayer AS. Infective endocarditis. Clin Infect Dis. 1993;17:313-320.
2. Steckelberg JM, Melton LJ III, Ilstrup DM, Rouse MS, Wilson WR. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med. 1990;88:582-588.
3. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:3167-3184.
4. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med. 2001;345:1318-1330.
5. Berlin JA, Abrutyn E, Strom BL, et al. Incidence of infective endocarditis in the Delaware Valley, 1988-1990. Am J Cardiol. 1995;76:933-936.
6. Weinberger I, Rotenberg Z, Zacharovitch D, Fuchs J, Davidson E, Agmon J. Native valve infective endocarditis in the 1970s versus the 1980s: underlying cardiac lesions and infecting organisms. Clin Cardiol. 1990;13:94-98.
7. Steckelberg JM, Wilson WR. Risk factors for infective endocarditis. Infect Dis Clin North Am. 1993;7:9-19.
8. Michel PL, Acar J. Native cardiac disease predisposing to infective endocarditis. Eur Heart J. 1995;16(suppl B):2-6.
9. Grover FL, Cohen DJ, Oprian C, Henderson WG, Sethi G, Hammermeister KE. Determinants of the occurrence of and survival from prosthetic valve endocarditis: experience of the Veterans Affairs Cooperative Study on Valvular Heart Disease. J Thorac Cardiovasc Surg. 1994;108:207-214.
10. Millaire A, Van Belle E, de Groote P, Leroy O, Ducloux G. Obstruction of the left main coronary ostium due to an aortic vegetation: survival after early surgery. Clin Infect Dis. 1996;22:192-193.
11. Graves MK, Soto L. Left-sided endocarditis in parenteral drug abusers: recent experience at a large community hospital. South Med J. 1992;85:378-380.
12. Tornos MP, Permanyer-Miralda G, Olona M, et al. Long-term complications of native valve infective endocarditis in non-addicts: a 15-year follow-up study. Ann Intern Med. 1992;117:567-572.
13. Bestetti RB, Figueiredo JF, Da Costa JC. Salmonella tricuspid endocarditis in an intravenous drug abuser with human immunodeficiency virus infection. Int J Cardiol. 1991;30:361-362.
14. McCarthy JT, Steckelberg JM. Infective endocarditis in patients receiving long-term hemodialysis. Mayo Clin Proc. 2000;75:1008-1014.
15. Fowler VG, Durack DT. Infective endocarditis. Curr Opin Cardiol. 1994; 9:389-400.
16. Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:3012-3021.
17. Tleyjeh IM, Steckelberg JM, Murad HS, et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA. 2005;293:3022-3028.
18. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation. 1998;98:2936-2948.
19. Werner AS, Cobbs CG, Kaye D, Hook EW. Studies on the bacteremia of bacterial endocarditis. JAMA. 1967;202:199-203.
20. Berbari EF, Cockerill FR III, Steckelberg JM. Infective endocarditis due to unusual or fastidious microorganisms. Mayo Clin Proc. 1997;72:532-542.
21. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003;108:1146-1162.
22. Lindner JR, Case RA, Dent JM, Abbott RD, Scheld WM, Kaul S. Diagnostic value of echocardiography in suspected endocarditis: an evaluation based on the pretest probability of disease. Circulation. 1996;93:730-736.
23. Omari B, Shapiro S, Ginzton L, et al. Predictive risk factors for periannular extension of native valve endocarditis: clinical and echocardiography analyses. Chest. 1989;96:1273-1279.
24. Arnett EN, Roberts WC. Valve ring abscess in active infective endocarditis: frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients. Circulation. 1976;54:140-145.
25. Daniel WG, Mugge A, Martin RP, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991;324:795-800.
26. Abad C. Acute infectious mitroaortic endocarditis in association with acute aortic dissection: surgical management of an unusual combination of diseases. Cardiovasc Surg. 1995;3:605-606.
27. Roder BL, Wandall DA, Espersen F, Frimodt-Moller N, Skinhoj P, Rosdahl VT. Neurologic manifestations in Staphylococcus aureus endocarditis: a review of 260 bacteremic cases in nondrug addicts. Am J Med. 1997; 102:379-386.
28. Parrino PE, Kron IL, Ross SD, et al. Does a focal neurologic deficit contraindicate operation in a patient with endocarditis? Ann Thorac Surg. 1999;67:59-64.
29. Kupferwasser LI, Hafner G, Mohr-Kahaly S, Erbel R, Meyer J, Darius H. The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events. J Am Coll Cardiol. 1999;33:1365-1371.
30. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W. Fungal endocarditis: evidence in the world literature, 1965-1995. Clin Infect Dis. 2001;32:50-62.
31. Steckelberg JM, Murphy JG, Ballard D, et al. Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med. 1991;114: 635-640.
32. Conlon PJ, Jefferies F, Krigman HR, Corey GR, Sexton DJ, Abramson MA. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis. Clin Nephrol. 1998;49:96-101.
33. Speechly-Dick ME, Swanton RH. Osteomyelitis and infective endocarditis. Postgrad Med J. 1994;70:885-890.
34. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:450-527.
35. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006; 48:1-148.
36. Kay PH, Oldershaw PJ, Dawkins K, Lennox SC, Paneth M. The results of surgery for active endocarditis of the native aortic valve. J Cardiovasc Surg (Torino). 1984;25:321-327.
37. Levine DP, Fromm BS, Reddy BR. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis . Ann Intern Med. 1991;115:674-680.
38. Calderwood SB, Swinski LA, Karchmer AW, Waternaux CM, Buckley MJ. Prosthetic valve endocarditis: analysis of factors affecting outcome of therapy. J Thorac Cardiovasc Surg. 1986;92:776-783.
39. Heinle S, Wilderman N, Harrison JK, et al, Duke Endocarditis Service. Value of transthoracic echocardiography in predicting embolic events in active infective endocarditis. Am J Cardiol. 1994;74:799-801.
40. Rohmann S, Erbel R, Darius H, et al. Prediction of rapid versus prolonged healing of infective endocarditis by monitoring vegetation size. J Am Soc Echocardiogr. 1991;4:465-474.